To the full analysis
Guardian Pharmacy Services stock: growth
GRDNGuardian Pharmacy Services reported $1.45B in revenue for fiscal 2025, up 17.9% on the prior year, up 14.5% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
13.4%
per year from 2018 to 2025, per share 13%
Earnings (Annual rate)
18.9%
per year from 2018 to 2025, per share 18.6%
Free cash flow (Annual rate)
13.3%
per year from 2018 to 2025, per share 12.9%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2018 | |
|---|---|---|
| Revenue | 14.5% | 13.4% |
| Revenue per share | 13.9% | 13.0% |
| Earnings | 19.8% | 18.9% |
| Earnings per share | 19.1% | 18.6% |
| Free cash flow | 12.8% | 13.3% |
| Free cash flow per share | 12.2% | 12.9% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2018 | $600.37M | $14.68M | $33.67M |
| 2019 | $698.29M | $21.75M | $41.62M |
| 2020 | $735.96M | $19.94M | $44.27M |
| 2021 | $792.07M | $16.31M | $49.22M |
| 2022 | $908.91M | $35.42M | $31.75M |
| 2023 | $1.05B | $23.9M | $56.26M |
| 2024 | $1.23B | −$87.29M | $41.59M |
| 2025 | $1.45B | $49.22M | $80.71M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 13 Mar 2026)
- Valuation signal Overvalued since 7 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.